157 related articles for article (PubMed ID: 34329654)
1. A multi-centre analysis of adjuvant contact X-ray brachytherapy (CXB) in rectal cancer patients treated with local excision - Preliminary results of the CONTEM1 study.
Dhadda A; Sun Myint A; Thamphya B; Hunter I; Hershman M; Gerard JP
Radiother Oncol; 2021 Sep; 162():195-201. PubMed ID: 34329654
[TBL] [Abstract][Full Text] [Related]
2. Organ or sphincter preservation for rectal cancer. The role of contact X-ray brachytherapy in a monocentric series of 112 patients.
Frin AC; Evesque L; Gal J; Benezery K; François E; Gugenheim J; Benizri E; Château Y; Marcié S; Doyen J; Gérard JP
Eur J Cancer; 2017 Feb; 72():124-136. PubMed ID: 28027515
[TBL] [Abstract][Full Text] [Related]
3. The safety and efficacy of total mesorectal excision (TME) surgery following dose-escalation: Surgical outcomes from the organ preservation in early rectal adenocarcinoma (OPERA) trial, a European multicentre phase 3 randomised trial (NCT02505750).
Sun Myint A; Rao C; Barbet N; Thamphya B; Pace-Loscos T; Schiappa R; Magné N; Martel-Lafay I; Mineur L; Deberne M; Zilli T; Dhadda A; Gerard JP
Colorectal Dis; 2023 Nov; 25(11):2160-2169. PubMed ID: 37837240
[TBL] [Abstract][Full Text] [Related]
4. Survival analysis of local excision vs total mesorectal excision for middle and low rectal cancer in pT1/pT2 stage and intermediate pathological risk.
Lai IL; You JF; Chern YJ; Tsai WS; Chiang JM; Hsieh PS; Hung HY; Yeh CY; Chiang SF; Lai CC; Tang RP; Chen JS; Hsu YJ
World J Surg Oncol; 2019 Dec; 17(1):212. PubMed ID: 31818295
[TBL] [Abstract][Full Text] [Related]
5. Dose Escalation Using Contact X-ray Brachytherapy After External Beam Radiotherapy as Nonsurgical Treatment Option for Rectal Cancer: Outcomes From a Single-Center Experience.
Sun Myint A; Smith FM; Gollins S; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman M; Pritchard DM
Int J Radiat Oncol Biol Phys; 2018 Mar; 100(3):565-573. PubMed ID: 29229327
[TBL] [Abstract][Full Text] [Related]
6. A cohort study of local excision followed by adjuvant therapy incorporating a contact X-ray brachytherapy boost instead of radical resection in 180 patients with rectal cancer.
Smith FM; Pritchard DM; Wong H; Whitmarsh K; Hershman MJ; Sun Myint A
Colorectal Dis; 2019 Jun; 21(6):663-670. PubMed ID: 30742736
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of oncological outcomes after local excision of pT1-2 rectal cancer requiring adjuvant (chemo)radiotherapy or completion surgery.
Borstlap WA; Coeymans TJ; Tanis PJ; Marijnen CA; Cunningham C; Bemelman WA; Tuynman JB
Br J Surg; 2016 Aug; 103(9):1105-16. PubMed ID: 27302385
[TBL] [Abstract][Full Text] [Related]
8. Dose escalation using contact X-ray brachytherapy (Papillon) for rectal cancer: does it improve the chance of organ preservation?
Sun Myint A; Smith FM; Gollins SW; Wong H; Rao C; Whitmarsh K; Sripadam R; Rooney P; Hershman MJ; Fekete Z; Perkins K; Pritchard DM
Br J Radiol; 2017 Dec; 90(1080):20170175. PubMed ID: 28937269
[TBL] [Abstract][Full Text] [Related]
9. Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV.
Gerard JP; Myint AS; Barbet N; Dejean C; Thamphya B; Gal J; Montagne L; Vuong T
Cancers (Basel); 2022 Mar; 14(5):. PubMed ID: 35267621
[TBL] [Abstract][Full Text] [Related]
10. Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.
Gérard JP; Barbet N; Gal J; Dejean C; Evesque L; Doyen J; Coquard R; Gugenheim J; Benizri E; Schiappa R; Baudin G; Benezery K; François E
Eur J Cancer; 2019 Feb; 108():1-16. PubMed ID: 30580125
[TBL] [Abstract][Full Text] [Related]
11. Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E; Vendrely V; Asselineau J; Rouanet P; Tuech JJ; Valverde A; de Chaisemartin C; Rivoire M; Trilling B; Jafari M; Portier G; Meunier B; Sieleznieff I; Bertrand M; Marchal F; Dubois A; Pocard M; Rullier A; Smith D; Frulio N; Frison E; Denost Q
Lancet Gastroenterol Hepatol; 2020 May; 5(5):465-474. PubMed ID: 32043980
[TBL] [Abstract][Full Text] [Related]
12. Anterior resection for rectal cancer with mesorectal excision: a prospective evaluation of 622 patients.
Law WL; Chu KW
Ann Surg; 2004 Aug; 240(2):260-8. PubMed ID: 15273550
[TBL] [Abstract][Full Text] [Related]
13. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
14. Adjuvant chemoradiotherapy instead of revision radical resection after local excision for high-risk early rectal cancer.
Jeong JU; Nam TK; Kim HR; Shim HJ; Kim YH; Yoon MS; Song JY; Ahn SJ; Chung WK
Radiat Oncol; 2016 Sep; 11(1):114. PubMed ID: 27595767
[TBL] [Abstract][Full Text] [Related]
15. Contact X-ray brachytherapy (CXB) as a salvage treatment for rectal cancer patients who developed local tumor re-growth after watch-and-wait approach.
Than NW; Pritchard DM; Duckworth CA; Hughes DM; Wong H; Sripadam R; Myint AS
J Contemp Brachytherapy; 2024 Apr; 16(2):95-102. PubMed ID: 38808203
[TBL] [Abstract][Full Text] [Related]
16. Planned organ preservation for elderly patients with rectal cancer using short course radiotherapy and a contact brachytherapy boost-an International multi-institution analysis.
Steinke J; Jordan C; Rossides S; Minnaar H; Yu J; Franklin A; Rockall T; Dhadda AS; Andrew Hunter I; Mills J; Chadwick E; Silverman R; Folkesson J; Radu C; Myint AS; Stewart AJ
Clin Transl Radiat Oncol; 2023 Mar; 39():100580. PubMed ID: 36686563
[TBL] [Abstract][Full Text] [Related]
17. Local excision of T1 and T2 rectal cancer: proceed with caution.
Elmessiry MM; Van Koughnett JA; Maya A; DaSilva G; Wexner SD; Bejarano P; Berho M
Colorectal Dis; 2014 Sep; 16(9):703-9. PubMed ID: 24787457
[TBL] [Abstract][Full Text] [Related]
18. Optimisation of Organ Preservation treatment strategies in patients with rectal cancer with a good clinical response after neoadjuvant (chemo)radiotherapy: Additional contact X-ray brachytherapy versus eXtending the observation period and local excision (OPAXX) - protocol for two multicentre, parallel, single-arm, phase II studies.
Geubels BM; van Triest B; Peters FP; Maas M; Beets GL; Marijnen CAM; Custers PA; Rutten HJT; Theuws JCM; Verrijssen AE; Cnossen JS; Burger JWA; Grotenhuis BA
BMJ Open; 2023 Dec; 13(12):e076866. PubMed ID: 38159950
[TBL] [Abstract][Full Text] [Related]
19. Local excision followed by early radical surgery in rectal cancer: long-term outcome.
Junginger T; Goenner U; Hitzler M; Trinh TT; Heintz A; Wollschläger D
World J Surg Oncol; 2019 Oct; 17(1):168. PubMed ID: 31594546
[TBL] [Abstract][Full Text] [Related]
20. Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial.
Bahadoer RR; Dijkstra EA; van Etten B; Marijnen CAM; Putter H; Kranenbarg EM; Roodvoets AGH; Nagtegaal ID; Beets-Tan RGH; Blomqvist LK; Fokstuen T; Ten Tije AJ; Capdevila J; Hendriks MP; Edhemovic I; Cervantes A; Nilsson PJ; Glimelius B; van de Velde CJH; Hospers GAP;
Lancet Oncol; 2021 Jan; 22(1):29-42. PubMed ID: 33301740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
